ED
BDSI

Exane Derivatives’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Exane Derivatives’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,923
Closed -$40.7K – 887
2020
Q3 		$40.7K Buy
10,923
+5,563
+104% +$23.7K 0.01% 385
2020
Q2 		$23.4K Buy
+5,360
New +$24.1K 0.01% 394

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exane Derivatives's BDSI Position: Q4 2020 in Review

Exane Derivatives sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2020, closing a stake of 10,923 shares — an estimated $40.7K sold.

Exane Derivatives first reported a position in BDSI in Q2 2020 and held it in 2 quarters. The position peaked at $40.7K in Q3 2020. 145 funds tracked by Wall St. Rank hold BDSI as of Q4 2020.

  • Exane Derivatives reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2020 after selling out during the quarter.
  • Exane Derivatives sold 10,923 BioDelivery Sciences International, Inc. shares in Q4 2020, an estimated $40.7K.
  • Exane Derivatives first reported a position in BioDelivery Sciences International, Inc. in Q2 2020 and held it in 2 quarters.
  • Exane Derivatives's BioDelivery Sciences International, Inc. position peaked at $40.7K in Q3 2020.
  • 145 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.